BBI Solutions (BBI) has vastly increased its antibodies range across a wide variety of disease areas, including bone metabolism, cardiac, growth factors, thyroid and sepsis. This range extension has been in response to growing demand in the IVD market.
The IVD industry is estimated to grow to $75.1 billion by 2020, at a CAGR of 5.8% from 2015 to 2020. BBI has already noticed an increased demand for antibodies and have expanded their antibodies range in response to customer enquiries.
Some of the products already proving to be popular in the new range are vitamin D2 and D3, procalcitonin and NT-proBNP. The vitamin D2 and D3 products will help with the diagnosis and monitoring of vitamin D deficiencies. Deficiencies in Vitamin D can be a risk factor for a number of medical conditions including, osteomalacia, rickets and osteoporosis.
Procalcitonin (PCT) is an ideal marker for early sepsis diagnosis. Levels in the blood of healthy patients are usually very low. However, levels can increase quickly within 3-6 hours of systemic infections or inflammation caused by bacterial infections. Therefore, PCT antibodies can be used in assays to monitor the progression of the disease and the effectiveness of treatment.
NT-proBNP is a biomarker used in the diagnosis of heart failure. Raised levels are associated with increased mortality in heart failure patients.
Dr James Steggles, BBI’s Commercial Manager for Antibodies, stated: “As a company, we want to be the go-to name for antibodies, and we hope that having a comprehensive portfolio of high performance products will make us exactly that. We have already noticed the increasing demand for antibodies in IVD, especially within China. By keeping quality as a first priority we will contribute to the continual improvement of personal healthcare worldwide.”
Each of our new antibodies has been tested in ELISA or Lateral Flow assay formats with high specificity and sensitivity results. Customers can access more information on BBI’s full range of antibodies and order product samples at www.bbisolutions.com.